Discovery of molecular associations among aging, stem cells, and cancer based on gene expression profiling

Chinese Journal of Cancer

Volumn 32, Issue 4, 2013, Pages 155-161

  Wang, Xiaosheng ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Aging; Cancer; Cancer informatics; Gene expression profiling; Stem cells

Indexed keywords

APOLIPOPROTEIN D; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; NOTCH RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; PAIRED BOX TRANSCRIPTION FACTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN FOS; PROTEIN MYB; PROTEIN P53; PROTEIN P63; SMAD PROTEIN; SOMATOMEDIN C; SONIC HEDGEHOG PROTEIN; STAT PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR POU; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

AGING; APOPTOSIS; CANCER GROWTH; CANCER RESEARCH; CANCER STEM CELL; CARCINOGENESIS; CELL CYCLE REGULATION; CELL DAMAGE; CELL FATE; DNA REPAIR; EMBRYONIC STEM CELL; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GERM CELL TUMOR; HUMAN; HUMAN GENOME; IMMUNE RESPONSE; INTRACELLULAR SIGNALING; METABOLISM; MICROARRAY ANALYSIS; NEOPLASM; ONCOGENE C MYC; ONCOGENE MYB; REVIEW; STEM CELL; STEM CELL RESEARCH; TUMOR SUPPRESSOR GENE;

AGING; APOPTOSIS; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROARRAY ANALYSIS; NEOPLASMS; NEOPLASTIC STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84875863445     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.012.10114     Document Type: Review

References (47)

1. Wang X. Computational analysis of expression of human embryonic stem cell associated signatures in tumors. BMC Res Notes, 2011,4:471.
2. BenPorath I, Thomson MW, Carey VJ, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet, 2008,40:499-507.
3. Wang X. Microarray analysis of ageing related signatures and their expression in tumors based on a computational biology approach. Genomics Proteomics Bioinformatics, 2012,10:136-141.
4. Lu T, Pan Y, Kao SY, et al. Gene regulation and DNA damage in the ageing human brain. Nature, 2004,429:883-891.
5. Erraji Benchekroun L, Underwood MD, Arango V, et al. Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry, 2005,57:549-558.
6. Hawse JR, Hejtmancik JF, Huang Q, et al. Identification and functional clustering of global gene expression differences between human age related cataract and clear lenses. Mol Vis, 2003,9:515-537.
7. Melk A, Mansfield ES, Hsieh SC, et al. Transcriptional analysis of the molecular basis of human kidney aging using cdna microarray profiling. Kidney Int, 2005,68:2667-2679.
8. Rodwell GEJ, Sonu R, Zahn JM, et al. A transcriptional profile of aging in the human kidney. PLoS Biol, 2004,2:e427.
9. Welle S, Brooks AI, Delehanty JM, et al. Gene expression profile of aging in human muscle. Physiol Genomics, 2003,14: 149-159.
10. Welle S, Brooks AI, Delehanty JM, et al. Skeletal muscle gene expression profiles in 20 -29 year old and 65 -71 year old women. Exp Gerontol, 2004,39:369-377.
11. Zahn JM, Sonu R, Vogel H, et al. Transcriptional profiling of aging in human muscle reveals a common aging signature. PLoS Genet, 2006,2:e115.
12. Lener T, Moll PR, Rinnerthaler M, et al. Expression profiling of aging in the human skin. Exp Gerontol, 2006,41:387-397.
13. Visala Rao D, Boyle GM, Parsons PG, et al. Influence of ageing, heat shock treatment and in vivo total antioxidant status on gene expression profile and protein synthesis in human peripheral lymphocytes. Mech Ageing Dev, 2003,124: 55-69.
14. de Magalhaes JP, Budovsky A, Lehmann G, et al. The human ageing genomic resources: online databases and tools for biogerontologists. Aging Cell, 2009,8:65-72.
15. Choi EK, Uyeno S, Nishida N, et al. Alterations of cfos gene methylation in the processes of aging and tumorigenesis in human liver. Mutat Res, 1996,354:123-128.
16. Flachsbart F, Caliebe A, Kleindorp R, et al. Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc Nat Acad Sci U S A, 2009,106:2700-2705.
17. Arden KC. Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer. Exp Gerontol, 2006,41:709-717.
18. Keyes WM, Mills AA. p63: a new link between senescence and aging. Cell Cycle, 2006,5:260-265.
19. Tomkova K, Tomka M, Zajac V. Contribution of p53, p63, and p73 to the developmental diseases and cancer. Neoplasma, 2008,55:177-181.
20. Muffat J, Walker DW. Apolipoprotein D: an overview of its role in aging and age-re lated diseases. Cell Cycle, 2010,9:269-273.
21. Anisimov VN. Insulin/IGF-1 signaling pathway driving aging and cancer as a target for pharmacological intervention. Exp Gerontol, 2003,38:1041-1049.
22. Laoukili J, Stahl M, Medema RH. FoxM1: at the crossroads of ageing and cancer. Biochim Biophys Acta, 2007,1775:92-102.
23. Young RA. Control of the embryonic stem cell state. Cell, 2011,144:940-954.
24. Boyer LA, Lee TI, Cole MF, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell, 2005,122:947-956.
25. Gangaraju VK, Lin H. MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol, 2009,10:116-125.
26. Smith K, Dalton S. Myc transcription factors: key regulators behind establishment and maintenance of pluripotency. Regen Med, 2010,5:947-959.
27. Chen X, Xu H, Yuan P, et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell, 2008,133:1106-1117.
28. Kim J, Chu J, Shen X, et al. An extended transcriptional network for pluripotency of embryonic stem cells. Cell, 2008,132:1049-1061.
29. Hassan KA, Chen G, Kalemkerian GP, et al. An embryonic stem cell-lik e signature identifies poorly differentiated lung adenocarcinoma but not squamous cell carcinoma. Clin Cancer Res, 2009,15:6386-6390.
30. Schoenhals M, Kassambara A, De Vos J, et al. Embryonic stem cell markers expression in cancers. Biochem Biophys Res Commun, 2009,383:157-162.
31. Kashyap V, Rezende NC, Scotland KB, et al. Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev, 2009,18:1093-1108.
32. Ben-David U, Benvenisty N. The tumorigenici ty of human embryonic and induced pluripotent stem cells. Nat Rev Cancer, 2011,11:268-277.
33. Kim J, Woo AJ, Chu J, et al. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell, 2010,143:313-324.
34. Kidder BL, Yang J, Palmer S. Stat3 and c-myc genome-wide promoter occupancy in embryonic stem cells. PLoS One, 2008,3:e3932.
35. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007,131:861-872.
36. Lin SL, Chang DC, Ying SY, et al. MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways. Cancer Res, 2010,70:9473-9482.
37. Lin SL, Chang DC, Chang-Lin S, et al. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-lik e state. RNA, 2008,14:2115-2124.
38. Lee NS, Kim JS, Cho WJ, et al. miR-302b maintains stemness of human embryonal carcinoma cells by post-transcriptional regulation of Cyclin D2 expression. Biochem Biophys Res Commun, 2008,377:434-440.
39. Murray MJ, Saini HK, van Dongen S, et al. The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression. Mol Cancer, 2010,9: 290.
40. Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-20 5 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol, 2008,10:593-601.
41. Shimono Y, Zabala M, Cho RW, et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell, 2009,138:592-603.
42. Vallejo DM, Caparros E, Dominguez M. Targeting notch signalling by the conserved miR-8/ 200 microRNA family in development and cancer cells. EMBO J, 2011,30:756-769.
43. Murat A, Migliavacca E, Gorlia T, et al. Stem cell-related self-renewal signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol, 2008,26: 3015-3024.
44. Santagata S, Ligon KL, Hornick JL. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors. Am J Surg Pathol, 2007,31:836-845.
45. Glinsky GV. Stemness genomics law governs clinical behavior of human cancer: implications for decision making in disease management. J Clin Oncol, 2008,26:2846-2853.
46. Ozsolak F, Milos PM. RNA sequencing: advances, challenges and opportunities. Nat Rev Genet, 2011,12:87-98.
47. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet, 2009,10:57-63.